Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
Headache: The Journal of Head and Face Pain · 2026-05 · 66 (5) · 1181-1192
DOI: 10.1111/head.70051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 04.03.2026. Verfasst von Stephen Silberstein und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Anti-Inflammatory Agents, Non-Steroidal, Analgesics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Axsome Therapeutics.
Abstract (Originalsprache)
Objective
To highlight key factors required to optimize multi‐mechanistic approaches with oral combination treatments for the acute management of a migraine attack.
Background
Given the complex multi‐factorial nature of migraine, combining treatments with different mechanisms of action should improve outcomes compared to monotherapies, but this has not been demonstrated with all treatment combinations.
Methods
For this narrative review, we searched PubMed using combinations of these terms: migraine, acute treatment, combination therapy, fixed‐dose combination therapy, multi‐mechanistic treatment, pharmacokinetics, and pharmacodynamics. All articles considered relevant were included.
Results
None of the existing migraine acute treatments as monotherapy effectively treat the key pathophysiological processes of migraine completely. Many patients do not achieve 2‐h pain freedom, which is key to avoiding migraine recurrence, medication overuse leading to chronification, and migraine‐related disability. The development of combination approaches has led to only two combinations with demonstrated superiority over their individual components: aspirin/acetaminophen/caffeine and sumatriptan/naproxen sodium. The latter is the most effective proven combination treatment because it targets peripheral activation of central pain pathways during the early migraine stages and central sensitization that develops later, independent of peripheral input. Other triptan/nonsteroidal anti‐inflammatory drug combinations with higher efficacy as monotherapies could be more effective than sumatriptan/naproxen sodium, particularly if their pharmacokinetic profiles align with the vasoactive mediators of peripheral and central sensitization that they target.
Conclusions
Combination treatments with different mechanisms of action targeting key distinct pathophysiological processes of migraine may be more effective than monotherapies, particularly if their pharmacokinetic profiles are optimized to target those processes at the right time. Further research in this area is warranted. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Förderung
- Axsome Therapeutics
Zitieren
APA
Silberstein, S., & Rapoport, A. M. (2026). Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review. Headache: The Journal of Head and Face Pain, 66(5), 1181-1192. https://doi.org/10.1111/head.70051
Vancouver
Silberstein S, Rapoport AM. Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review. Headache: The Journal of Head and Face Pain. 2026;66(5):1181-1192. doi:10.1111/head.70051
BibTeX
@article{Silberstein2026,
author = {Silberstein, Stephen and Rapoport, Alan M},
title = {Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
volume = {66},
number = {5},
pages = {1181--1192},
doi = {10.1111/head.70051}
}
EUVIMED